Inside these posts: Drug testing

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Pfizer rival to Abbott arthritis drug partially meets trial goals

Pfizer Inc. said on Friday its experimental rheumatoid arthritis drug met most of the main goals of a late-stage clinical trial.

If approved, it would compete with injectable treatments such as Humira, made by Abbott Laboratories, Amgen Inc.’s Enbrel, and Remicade, made by Johnson & Johnson. Get the full story »

Lundbeck seeks FDA approval of epilepsy drug

Lundbeck Inc. said the U.S. Food and Drug Administration will review its experimental drug for a rare epilepsy disorder.

Deerfield-based Lundbeck, the U.S. subsidiary of Denmark’s H. Lundbeck SA, said the drug, clobazam, is a therapy used to treat “seizures associated with Lennox-Gastaut syndrome in patients two years and older.” Known as “LGS,” the disease is typically diagnosed in childhood, the company said. Lundbeck hopes to eventually market the drug here under the trade name Onfi. Get the full story »

BioSante shares up after cancer drug meets goals

BioSante Pharmaceuticals Inc. said Thursday its potential pancreatic cancer treatment met key goals in a midstage study.

The company’s stock surged 32 cents, or 16 percent, to $2.35 in premarket trading.

The company said a newly published study showed the vaccine increased the median survival rate of patients by more than 25 percent to 24.8 months. The results were published in the February issue of the Annals of Surgery and involved 60 patients undergoing treatment at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore. Get the full story »

Genzyme makes case for demanding higher Sanofi bid

Genzyme Corp. made its case for why it is worth more than Sanofi-Aventis’s $18.5 billion offer, forecasting 2011 profit above Wall Street estimates and sales of $3 billion for its experimental multiple sclerosis drug. Get the full story »

Wal-Mart sued for firing legal pot smoker

Michigan man has sued Wal-Mart Stores Inc. for firing him after he tested positive for medical marijuana he was using legally to treat pain from an inoperable brain tumor and sinus cancer. Joseph Casias, 30, said he was fired late last year after five years of employment at a Wal-Mart store in his hometown of Battle Creek. Get the full story »